Name: | Description: | Size: | Format: | |
---|---|---|---|---|
322.25 KB | Adobe PDF |
Authors
Advisor(s)
Abstract(s)
Background: Parkinson’s disease is the second most important neurodegenerative disorder,
affecting 3% of individuals older than 80 years of age. Main clinical symptoms are resting tremor, postural
instability, bradykinesia and rigidity, with a good response to levodopa therapy.
Purpose of the study: The main goal of this work is to make a deep analysis on the genetic factors
and kind of heritage involved in the development of Parkinson.
Main fi ndings: Over the last years, numerous studies allowed to confirm the unquestionable
contribution of genetic factors to the complex pathogenesis of this disease. Highly penetrant mutations
producing rare, monogenic forms of the disease have been identifi ed in singular genes such as SNCA,
Parkin, DJ-1, PINK1, LRRK2, and VPS35. Unique variants with incomplete penetrance in LRRK2 and GBA
genes were identifi ed as strong risk factors for Parkinson’s disease in certain populations. Additionally,
over 20 common variants with small effect sizes are now recognized to modulate the risk for Parkinson’s
disease.
Investigating Mendelian forms of Parkinson disease has provided precious insight into the
pathophysiology that underlies the more common idiopathic form of this disorder.
Conclusions: The challenge over the next decade will be to get more data that strengthens the already
available knowledge concerning genetics on Parkinson’s disease, through the discovery of biological
consequences of risk variants. Moreover, it is also expected that the advent of genome-wide association
studies and the implementation of new research technologies will help in the identifi cation of novel risk
variants for the sporadic forms of Parkinson disease.
Description
Keywords
Parkinson’s disease Genes involved Risk Alleles